GANX
#4048
Gain Therapeutics, Inc. - Common Stock
1.7 9 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.13%
Changement Mensuel
+2.87%
Evolution sur 6 mois
-33.21%
Changement Annuel
-8.21%
Clôture Précédente
1.7 7
Open
1.7 9
Low
1.7 9
High
1.7 9
Volume
16
Financials
- Market Capitalization 78.12 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.gaintherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00W7D7CJ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.06
ratio cours/chiffre d'affaires
-331.68
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4017 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.06 USD | +2.91% | +8.16% | +11.58% | -45.92% | 82.46 M USD | ||
| 4025 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 4.52 USD | -0.66% | -2.16% | +3.91% | -9.05% | 81.93 M USD | ||
| 4054 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.12 USD | +1.82% | -3.45% | -10.40% | -5.08% | 77.03 M USD | ||
| 4061 |  NRXS Neuraxis, Inc. Common Stock | 6.01 USD | +4.70% | -2.28% | -13.15% | +10.68% | 75.47 M USD |